Eagle Pharmaceuticals, Inc.
EGRX · OTC
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $15,354 | $21,897 | $55,321 | $15,384 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $116,284 | $116,022 | $73,440 | $97,930 |
| Inventory | $42,482 | $44,140 | $47,794 | $63,855 |
| Other Curr. Assets | $3,820 | $11,501 | $13,200 | $8,875 |
| Total Curr. Assets | $187,250 | $192,491 | $188,754 | $185,046 |
| Property Plant & Equip (Net) | $1,013 | $1,116 | $1,168 | $1,297 |
| Goodwill | $45,033 | $45,033 | $45,033 | $41,794 |
| Intangibles | $107,406 | $112,875 | $118,327 | $108,785 |
| Long-Term Investments | $18,332 | $18,122 | $10,011 | $11,320 |
| Tax Assets | $30,715 | $29,150 | $27,146 | $23,541 |
| Other NC Assets | $15,073 | $15,388 | $15,721 | $18,284 |
| Total NC Assets | $217,572 | $221,684 | $217,406 | $205,021 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $404,822 | $414,175 | $406,160 | $390,067 |
| Liabilities | – | – | – | – |
| Payables | $15,843 | $17,108 | $18,993 | $13,215 |
| Short-Term Debt | $8,297 | $7,500 | $6,250 | $34,961 |
| Tax Payable | $1,158 | $12,583 | $5,182 | $5,750 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $2,456 | $3,319 | $10,842 | $18,494 |
| Total Curr. Liab. | $86,630 | $97,809 | $111,087 | $121,828 |
| LT Debt | $61,896 | $68,829 | $56,216 | $26,431 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $4,536 |
| Other NC Liab. | $4,256 | $4,692 | $1,508 | $0 |
| Total NC Liab. | $66,152 | $73,521 | $61,513 | $32,841 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1,422 | $1,587 | $1,534 | $3,382 |
| Total Liabilities | $152,782 | $171,330 | $172,600 | $154,669 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $18 | $18 | $18 | $18 |
| Retained Earnings | $122,418 | $117,254 | $111,504 | $106,957 |
| AOCI | -$1,112 | -$1,112 | -$1,112 | $9,377 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $252,040 | $242,845 | $233,560 | $235,398 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $404,822 | $414,175 | $406,160 | $390,067 |
| Net Debt | $54,839 | $54,432 | $7,145 | $46,008 |